C. Liang

Bioinformatics for differential proteomics data between triple-negative breast cancer and luminal A subtype breast cancer

G. Wu, Lei Zhang, Bo Chen, 2020 .

Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniques

Guogang Wu, Lei Zhang, Bo Chen, 2020 .

Consistency Analysis of Programmed Death-Ligand 1 Expression between Primary and Metastatic Non-Small Cell Lung Cancer: A Retrospective Study

Zhi Li, Su Yao, Xin-lan Luo, 2020, Journal of Cancer.

Nomogram for predicting the risk of bone metastasis in breast cancer: a SEER population-based study

Lijun Ye, Lei Zhang, Zining Jin, 2020, Translational cancer research.

U.S. prevalence of endocrine therapy-naïve locally advanced or metastatic breast cancer.

W. Gradishar, A. Nunes, J. Lewis, 2019, Current oncology.

Role of Ultrasound in the Diagnosis of Lymph Node Status in Axillary Lymph Node Metastases in Breast Cancer undergoing Neoadjuvant Chemotherapy

Lei Zhang, Guogang Wu, Zining Jin, 2019 .

Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.

Min Zhao, Lu Xu, Lijun Ye, 2018, American journal of translational research.